Inicio / Oncología / Abstracts de oncología / Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis

Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis

15 marzo, 2018 - 1 min.

★ ★ ★ ★ ★

0 / 5 (0 votos)

Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis

THE LANCET ONCOLOGY

Fecha de publicación: Marzo 2018

DOI: https://doi.org/10.1016/S1470-2045(18)30078-0

Autores: Jennifer L McQuade, Carrie R Daniel, Kenneth R Hess, Carmen Mak, Daniel Y Wang, Rajat R Rai, John J Park, Lauren E Haydu, Christine Spencer, Matthew Wongchenko, Stephen Lane, Dung-Yang Lee, Mathilde Kaper, Meredith McKean…

Background: Obesity has been linked to increased mortality in several cancer types; however, the relation between obesity and survival outcomes in metastatic melanoma is unknown. The aim of this study was to examine the association between body-mass index (BMI) and progression-free survival or overall survival in patients with metastatic melanoma who received targeted therapy, immunotherapy, or chemotherapy.

SEGUIR LEYENDO

Comentarios

Para dejar un comentario antes debes iniciar sesión:

¿No tienes una cuenta?

Regístrate a través de éste enlace.

Cookie	Duración	Descripción
cookielawinfo-checkbox-advertisement	1 year	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Advertisement".
cookielawinfo-checkbox-analytics	1 year	This cookies is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Analytics".
cookielawinfo-checkbox-necessary	1 year	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".

Cookie	Duración	Descripción
_ga	2 years	This cookie is installed by Google Analytics. The cookie is used to calculate visitor, session, campaign data and keep track of site usage for the site's analytics report. The cookies store information anonymously and assign a randomly generated number to identify unique visitors.
_gat_gtag_UA_5053722_88	1 minute	This cookie is set by Google and is used to distinguish users.
_gid	1 day	This cookie is installed by Google Analytics. The cookie is used to store information of how visitors use a website and helps in creating an analytics report of how the website is doing. The data collected including the number visitors, the source where they have come from, and the pages visted in an anonymous form.
uvc	1 year 1 month	The cookie is set by addthis.com to determine the usage of Addthis.com service.

Cookie	Duración	Descripción
__atuvc	1 year 1 month	This cookie is set by Addthis to make sure you see the updated count if you share a page and return to it before our share count cache is updated.
__atuvs	30 minutes	This cookie is set by Addthis to make sure you see the updated count if you share a page and return to it before our share count cache is updated.

Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis

Temáticas

Comentarios

¿No tienes una cuenta?

Study of bone metabolism and angiogenesis in patients undergoing high-dose…

Targeting the immune milieu in gastrointestinal cancers

Identifican el mecanismo del linfoma no Hodgkin para hacerse ‘invisible’

Los antibióticos mejoran la eficacia de la inmunoterapia frente al…

Un dispositivo portátil detecta si la quimio es demasiado agresiva

Inmunoterapia y quimioterapia: destinadas a entenderse

Treatment Outcomes for Metastatic Melanoma of Unknown Primary in the…

Nueva viroinmunoterapia para cáncer